Easton Pharmaceuticals Inc (EAPH) 0.0152 $EAPH
Easton and GW Pharmaceuticals Lead Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Aug 19, 9:02AM CDT
WHITEFISH, MT / ACCESSWIRE / August 19, 2014 / The Marijuana Index(TM) moved marginally higher last week, driven by a 7.71% rise in GW Pharmaceuticals plc (NASDAQ: GWPH) shares, which was partially offset by a 15.3% drop in Medbox Inc. (OTC: MDBX) shares.
Easton Pharmaceuticals Announces it has Reached a Manufacturing Agreement for the Company's OTC Products; Advances Timetable for Product Launch
ACCESSWIRE - Thu Aug 14, 9:45AM CDT
TORONTO, ON / ACCESSWIRE / August 14, 2014 / Easton Pharmaceuticals (OTC Pink: EAPH) (PINKSHEETS: EAPH) announces they have sourced out, come to terms and agreed to enter into an agreement with a manufacturing partner for the North American Market and is finalizing a manufacturing Agreement for the Latin American market. Company advances timetable towards its OTC product launches.
CBD Hemp Oil Product Potential Continues to Grow with Ongoing Scientific & Clinical Studies - Company Launches High CBD Hemp Oil for Sale in U.S.
PR Newswire - Mon Aug 11, 8:05AM CDT
The marijuana industry holds strong as new products hit market, companies test varying forms of cannabis therapies: Flameret Inc. (OTC: FLRE), GW Pharmaceuticals plc (NASDAQ: GWPH), Terra Tech Corp. (OTC: TRTC), American Green, Inc. (OTC: ERBB) and Easton Pharmaceuticals Inc. (OTC: EAPH)
Easton Pharmaceuticals Announces Medical Marijuana Site Facility Visit and Inspection
Marketwire - Mon Aug 11, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it was provided through a company agent / consultant, with a site visit / inspection of the medical marijuana grow-op facilities, located just outside of Toronto, Ontario, Canada pursuant to its previously announced option purchase agreement.
Easton Pharmaceuticals Announces the Completion and Shipping of the mPact -GROzone Antimicrobial System; Provides Other Updates
Marketwire - Wed Aug 06, 7:01AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has in keeping with its prior outlined timeline; made a site visit of the mPact -GROzone Antimicrobial System prior to shipping to one of the largest medical marijuana growers in the United States.
Easton Pharmaceuticals Provides Update on mPACT-Grozone 60(TM) and Other Corporate Initiatives
Marketwire - Wed Jul 16, 11:59AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) - Announces It is scheduled at the end of July to participate with Amfil Technologies Inc. in the introduction of the first mPACT-Grozone 60(TM) unit.
Easton Pharmaceuticals Announces Legal Action Against Seeking Alpha Writer as a Response to Libelous Article
Marketwire - Tue Jul 08, 2:00PM CDT
Easton Pharmaceuticals (OTC: EAPH) announces corporate response to libelous seeking alpha article.
Easton Pharmaceuticals Announces Closing of Agreement to Invest and Acquire Ownership Interest in AMFIL Technologies Inc. and the mPact -GROzone Antimicrobial Systems Line of Products
Marketwire - Tue Jul 08, 12:30PM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) - announces that it has advanced funds and closed on an agreement to invest and purchase an ownership interest in AMFIL Technologies Inc. and The mPact -GROzone Antimicrobial Systems Line of Products.
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
Daily OTC Stocks Trading List: Easton Pharmaceuticals, Inc. Virtus Oil and Gas Corp, Primco Management, Inc. Baltia Airlines, Inc. Alternative Fuels America, Inc.
PR Newswire - Tue Jul 08, 7:00AM CDT
After releasing positive news regarding their latest build out and working partnerships shares in Easton Pharmaceuticals (OTC: EAPH) had been on a string move higher over the last week. That changed yesterday when after an impressive run to the upside shares rolled over to close down 15.7% on the day. It remains to be seen if this was just profit taking or a trading pullback, either way if the stock can get back above the $0.025 level then it has more upside potential.
Easton Pharmaceuticals Inc. Announces Medical Marijuana Facility Buildout Nears Completion as per MMPR Health Canada Guidelines Prior to Inspection Towards Obtaining MMJ Growers License
Marketwire - Tue Jul 01, 7:01AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company provides status update on its medical marijuana initiative.
Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Easton Pharmaceuticals Finalizing Investment Terms in Private Medical Marijuana Device Company; Moves to Initiate Legal Action Against Libelous Seeking Alpha Article
Marketwire - Wed Jun 25, 12:17PM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) is near final agreement with a medical marijuana technology company specializing in controlled environment agricultural technologies.
CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Index™ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.
Easton Pharmaceuticals Announces Changes in Management and New Additions to Advisory Board; Appoints Dr. Albert PhD as New Marketing and Technology Officer and Appoints Tim Zorn, Current CEO of HempLifeToday.com to Advisory Board
Marketwire - Mon Mar 31, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) -- announces it has appointed Carla Pepe as its new CEO and President, replacing John Adams who will assume the position of CFO. The company also announces the addition of Dr. Lilla Albert PhD to the advisory board, chief marketing officer, and Mr. Tim Zorn, current CEO of HempLifeToday.com (OTC: GLCO) to advisory board.
Easton Pharmaceuticals Announces Signing LOI for Joint Venture Towards Private Medical Marijuana Colorado Grower and Licenses; Provides Clarification on Its Canadian Medical Marijuana Initiatives
Marketwire - Fri Mar 28, 9:45AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has signed a letter of intent for the creation of a possible JV with another US company towards a Private Medical Marijuana company in the state of Colorado.
Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development
Marketwire - Tue Mar 25, 7:46AM CDT
Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, announces it has entered into an agreement towards securing majority control of the cancer drug Xilive, pending certain conditions and a new partnership proposal towards medicinal marijuana.
Cannabis Science Finalizes $1 Million in New Financing
ACCESSWIRE - Wed Mar 19, 10:22AM CDT
A developer of cannabis-based pharmaceutical products Cannabis Science Inc. (NASDAQ OTC: CBIS) announced that it has finalized its $1,000,000 private placement and the funds have already been put into the bank.
Easton Pharmaceuticals Announces It Has Engaged Online Marketing and Branding Specialists to Support the Firm's Updated Products, Branding and Website Launch; Provides Update on Its Medical Marijuana Initiatives
Marketwire - Wed Mar 19, 7:43AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has hired marketing and branding specialists to support the firms brand and online marketing awareness, as well as provide an update on its medical marijuana initiatives.
Easton and GW Pharmaceuticals Lead Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Aug 19, 9:02AM CDT
WHITEFISH, MT / ACCESSWIRE / August 19, 2014 / The Marijuana Index(TM) moved marginally higher last week, driven by a 7.71% rise in GW Pharmaceuticals plc (NASDAQ: GWPH) shares, which was partially offset by a 15.3% drop in Medbox Inc. (OTC: MDBX) shares.
Easton Pharmaceuticals Announces it has Reached a Manufacturing Agreement for the Company's OTC Products; Advances Timetable for Product Launch
ACCESSWIRE - Thu Aug 14, 9:45AM CDT
TORONTO, ON / ACCESSWIRE / August 14, 2014 / Easton Pharmaceuticals (OTC Pink: EAPH) (PINKSHEETS: EAPH) announces they have sourced out, come to terms and agreed to enter into an agreement with a manufacturing partner for the North American Market and is finalizing a manufacturing Agreement for the Latin American market. Company advances timetable towards its OTC product launches.
CBD Hemp Oil Product Potential Continues to Grow with Ongoing Scientific & Clinical Studies - Company Launches High CBD Hemp Oil for Sale in U.S.
PR Newswire - Mon Aug 11, 8:05AM CDT
The marijuana industry holds strong as new products hit market, companies test varying forms of cannabis therapies: Flameret Inc. (OTC: FLRE), GW Pharmaceuticals plc (NASDAQ: GWPH), Terra Tech Corp. (OTC: TRTC), American Green, Inc. (OTC: ERBB) and Easton Pharmaceuticals Inc. (OTC: EAPH)
Easton Pharmaceuticals Announces Medical Marijuana Site Facility Visit and Inspection
Marketwire - Mon Aug 11, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it was provided through a company agent / consultant, with a site visit / inspection of the medical marijuana grow-op facilities, located just outside of Toronto, Ontario, Canada pursuant to its previously announced option purchase agreement.
Easton Pharmaceuticals Announces the Completion and Shipping of the mPact -GROzone Antimicrobial System; Provides Other Updates
Marketwire - Wed Aug 06, 7:01AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has in keeping with its prior outlined timeline; made a site visit of the mPact -GROzone Antimicrobial System prior to shipping to one of the largest medical marijuana growers in the United States.
Easton Pharmaceuticals Provides Update on mPACT-Grozone 60(TM) and Other Corporate Initiatives
Marketwire - Wed Jul 16, 11:59AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) - Announces It is scheduled at the end of July to participate with Amfil Technologies Inc. in the introduction of the first mPACT-Grozone 60(TM) unit.
Easton Pharmaceuticals Announces Legal Action Against Seeking Alpha Writer as a Response to Libelous Article
Marketwire - Tue Jul 08, 2:00PM CDT
Easton Pharmaceuticals (OTC: EAPH) announces corporate response to libelous seeking alpha article.
Easton Pharmaceuticals Announces Closing of Agreement to Invest and Acquire Ownership Interest in AMFIL Technologies Inc. and the mPact -GROzone Antimicrobial Systems Line of Products
Marketwire - Tue Jul 08, 12:30PM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) - announces that it has advanced funds and closed on an agreement to invest and purchase an ownership interest in AMFIL Technologies Inc. and The mPact -GROzone Antimicrobial Systems Line of Products.
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
Daily OTC Stocks Trading List: Easton Pharmaceuticals, Inc. Virtus Oil and Gas Corp, Primco Management, Inc. Baltia Airlines, Inc. Alternative Fuels America, Inc.
PR Newswire - Tue Jul 08, 7:00AM CDT
After releasing positive news regarding their latest build out and working partnerships shares in Easton Pharmaceuticals (OTC: EAPH) had been on a string move higher over the last week. That changed yesterday when after an impressive run to the upside shares rolled over to close down 15.7% on the day. It remains to be seen if this was just profit taking or a trading pullback, either way if the stock can get back above the $0.025 level then it has more upside potential.
Easton Pharmaceuticals Inc. Announces Medical Marijuana Facility Buildout Nears Completion as per MMPR Health Canada Guidelines Prior to Inspection Towards Obtaining MMJ Growers License
Marketwire - Tue Jul 01, 7:01AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company provides status update on its medical marijuana initiative.
Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Easton Pharmaceuticals Finalizing Investment Terms in Private Medical Marijuana Device Company; Moves to Initiate Legal Action Against Libelous Seeking Alpha Article
Marketwire - Wed Jun 25, 12:17PM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) is near final agreement with a medical marijuana technology company specializing in controlled environment agricultural technologies.
CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Index™ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.
Easton Pharmaceuticals Announces Changes in Management and New Additions to Advisory Board; Appoints Dr. Albert PhD as New Marketing and Technology Officer and Appoints Tim Zorn, Current CEO of HempLifeToday.com to Advisory Board
Marketwire - Mon Mar 31, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) -- announces it has appointed Carla Pepe as its new CEO and President, replacing John Adams who will assume the position of CFO. The company also announces the addition of Dr. Lilla Albert PhD to the advisory board, chief marketing officer, and Mr. Tim Zorn, current CEO of HempLifeToday.com (OTC: GLCO) to advisory board.
Easton Pharmaceuticals Announces Signing LOI for Joint Venture Towards Private Medical Marijuana Colorado Grower and Licenses; Provides Clarification on Its Canadian Medical Marijuana Initiatives
Marketwire - Fri Mar 28, 9:45AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has signed a letter of intent for the creation of a possible JV with another US company towards a Private Medical Marijuana company in the state of Colorado.
Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development
Marketwire - Tue Mar 25, 7:46AM CDT
Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, announces it has entered into an agreement towards securing majority control of the cancer drug Xilive, pending certain conditions and a new partnership proposal towards medicinal marijuana.
Cannabis Science Finalizes $1 Million in New Financing
ACCESSWIRE - Wed Mar 19, 10:22AM CDT
A developer of cannabis-based pharmaceutical products Cannabis Science Inc. (NASDAQ OTC: CBIS) announced that it has finalized its $1,000,000 private placement and the funds have already been put into the bank.
Easton Pharmaceuticals Announces It Has Engaged Online Marketing and Branding Specialists to Support the Firm's Updated Products, Branding and Website Launch; Provides Update on Its Medical Marijuana Initiatives
Marketwire - Wed Mar 19, 7:43AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has hired marketing and branding specialists to support the firms brand and online marketing awareness, as well as provide an update on its medical marijuana initiatives.
